Background: Late stent thrombosis (LST) often occurs by discontinuation of dual antiplatelet therapy (DAPT) after stenting for acute myocardial infarction (AMI), although the ACC/AHA guidelines recommend the continuation of DAPT for 1 year after stenting for AMI whether drug-eluting stent (DES) or bare-metal stent (BMS) is implanted. We evaluated the impact of clinical status, AMI or non-AMI, and discontinuation of DAPT on the prevalence of LST. patients (3726 lesions) were treated for AMI and 13671 patients (28781 lesions) for non-AMI, in whom we retrospectively reviewed clinical data of those with LST. LST was defined as stent thrombosis according to the Academic Research Consortium definition which occurs from 1 month to 1 year after procedure.
